Cargando…

A nomogram for the prediction of overall survival in patients with stage II and III non-small cell lung cancer using a population-based study

As a malignant tumor with poor prognosis, accurate and effective treatment of non-small cell lung cancer (NSCLC) is crucial. To predict overall survival in patients with stage II and III NSCLC, a nomogram was constructed using data from the Surveillance, Epidemiology and End Results database. Eligib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yi, Wang, Xue, Zhong, Ping, Yin, Guofang, Fan, Xianming, Huang, Chengliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865638/ https://www.ncbi.nlm.nih.gov/pubmed/31788064 http://dx.doi.org/10.3892/ol.2019.10977

Ejemplares similares

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis
por: Liao, Yi, et al.
Publicado: (2019)

The Positive Lymph Node Ratio Predicts Survival in T(1−4)N(1−3)M(0) Non-Small Cell Lung Cancer: A Nomogram Using the SEER Database
por: Liao, Yi, et al.
Publicado: (2020)

Identification of a methylomics-associated nomogram for predicting overall survival of stage I–II lung adenocarcinoma
por: Wang, Heng, et al.
Publicado: (2021)

A methylomics-associated nomogram predicts the overall survival risk of stage III to IV ovarian cancer
por: Wei, Xuan, et al.
Publicado: (2023)

Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database
por: Zhang, Shengchao, et al.
Publicado: (2023)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

A nomogram to predict the overall survival of patients with symptomatic extensive-stage small cell lung cancer treated with thoracic radiotherapy
por: Yuan, Xun, et al.
Publicado: (2021)

Identification of a visualized web-based nomogram for overall survival prediction in patients with limited stage small cell lung cancer
por: Liang, Min, et al.
Publicado: (2023)

Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer
por: Deng, Jianqing, et al.
Publicado: (2018)

Nomogram Predicting Overall Survival in Patients with FIGO II to III Squamous Cell Cervical Carcinoma Under Radical Radiotherapy: A Retrospective Analysis Based on 2018 FIGO Staging
por: Zang, Lele, et al.
Publicado: (2021)

Adding Erlotinib to Chemoradiation Improves Overall Survival but not Progression-Free Survival in Stage III Non-Small-Cell Lung Cancer
por: Komaki, Ritsuko, et al.
Publicado: (2015)

Nomogram for the prediction of individualized overall survival of patients diagnosed with small cell esophageal carcinoma
por: Liu, Di, et al.
Publicado: (2021)

Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer
por: Ren, Dan, et al.
Publicado: (2022)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

Nomogram for predicting overall survival time of patients with stage IV colorectal cancer
por: Lv, Min-Yi, et al.
Publicado: (2022)

Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study
por: Zhou, Zheng, et al.
Publicado: (2019)

A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy
por: Zeng, Yuan, et al.
Publicado: (2021)

A nomogram for predicting overall survival rate in patients with brain metastatic non-small cell lung cancer
por: Peng, Shanshan, et al.
Publicado: (2022)

New nomograms to predict overall and cancer‐specific survival of angiosarcoma
por: Liu, Yuan‐Yuan, et al.
Publicado: (2021)

Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer
por: Feng, Yifan, et al.
Publicado: (2021)

Nomogram to predict overall survival after gallbladder cancer resection in China
por: Bai, Yi, et al.
Publicado: (2018)

An immune-related nomogram model that predicts the overall survival of patients with lung adenocarcinoma
por: Sun, Jing, et al.
Publicado: (2022)

A novel nomogram to predict the overall survival of patients with colloid adenocarcinoma of the lung
por: Zhang, Jun, et al.
Publicado: (2021)

Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
por: Cho, Yerim, et al.
Publicado: (2023)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

Development and external validation of a nomogram for predicting the overall survival of patients with stage II nasopharyngeal carcinoma after curative treatment
por: He, Sha-Sha, et al.
Publicado: (2019)

Nomogram to predict overall survival and disease-specific survival with appendiceal mucinous adenocarcinoma
por: Yan, Qian, et al.
Publicado: (2019)

Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy
por: Yu, Shufei, et al.
Publicado: (2016)

A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients
por: Oberije, Cary, et al.
Publicado: (2015)

Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
por: Yang, Yaji, et al.
Publicado: (2021)

Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma
por: Liu, Qinglin, et al.
Publicado: (2020)

Surgery is a promising strategy for improving overall survival for stage III-N2 non-small cell lung cancer patients
por: Yang, Jie, et al.
Publicado: (2023)

Development and validation of nomograms for predicting overall and cancer-specific survival in young patients with non-small cell lung cancer
por: Peng, Yizhou, et al.
Publicado: (2020)

A novel nomogram to predict the overall survival in esthesinoeroblastoma
por: Jiang, Lijie, et al.
Publicado: (2020)

Nomograms to predict overall survival for patients with endometrial carcinosarcoma
por: Iavazzo, Christos, et al.
Publicado: (2023)

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
por: Zhang, Jieyun, et al.
Publicado: (2019)

Development and external validation of a nomogram to predict overall survival following stereotactic body radiotherapy for early-stage lung cancer
por: Baker, Sarah, et al.
Publicado: (2020)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_idvo6indke28su851mhqlpscog